Altimmune (ALT) FCF Margin (2010 - 2025)

Altimmune (ALT) has 16 years of FCF Margin data on file, last reported at 74803.85% in Q4 2025.

• FCF Margin for Q4 2025 came in at 74803.85%, up 29049615.0% year-over-year; the trailing twelve-month figure through Dec 2025 was 164721.95% (up 23451805.0% YoY), and the FY2025 annual result was 164746.34%, up 23449366.0% from the prior year.
• FCF Margin improved to 74803.85% in Q4 2025 per ALT's latest filing, from 237940.0% in the prior quarter.
• Over five years, FCF Margin peaked at 674.82% in Q4 2021 and troughed at 755500.0% in Q3 2022.
• A 5-year average of 210363.27% and a median of 150847.32% in 2023 frame the typical range for FCF Margin.
• The sharpest annual moves came in 2022 and 2023: FCF Margin tumbled 74420570 bps in 2022, then soared 74984061 bps in 2023.
• A 5-year view of FCF Margin shows it stood at 674.82% in 2021, then plunged by 9785 bps to 66707.69% in 2022, then soared by 33 bps to 44683.78% in 2023, then slumped by 718 bps to 365300.0% in 2024, then jumped by 80 bps to 74803.85% in 2025.
• Business Quant data shows ALT's FCF Margin at 74803.85% in Q4 2025, 237940.0% in Q3 2025, and 387000.0% in Q2 2025.